The autophagy protein RUBCNL/PACER represses RIPK1 kinase-dependent apoptosis and necroptosis

Diego Rojas-Rivera1,2, Sebastián Beltrán3,4,5, Francisco Muñoz-Carvajal1

  • 1Cell Death & Biomedicine Laboratory, Centro de Biomedicina, Universidad Mayor, Santiago, Chile.

Autophagy
|June 14, 2024
PubMed

Insights

RUBCNL protects mesenchymal stem cells (MSCs) from TNF-induced cell death by inhibiting RIPK1 signaling. This protein

Area of Science:

  • Cell Biology
  • Immunology
  • Biochemistry

Background:

  • Mesenchymal stem cells (MSCs) are crucial for cell therapy but exhibit poor survival in inflammatory environments.
  • Autophagy activation is a stress response in MSCs, maintaining cellular homeostasis.
  • RUBCNL/PACER, a known autophagy regulator, also influences cell death pathways.

Purpose of the Study:

  • To investigate the role of RUBCNL in MSC survival under stress conditions.
  • To elucidate the mechanism by which RUBCNL affects tumor necrosis factor (TNF)-induced cell death.
  • To explore RUBCNL's potential as a therapeutic target for enhancing MSC efficacy.

Main Methods:

  • Proteomics analysis to identify RUBCNL's involvement in cell death.
  • Functional screening of MSCs with altered RUBCNL expression under various cell death stimuli.
  • Analysis of RIPK1-dependent apoptosis and necroptosis pathways.
  • Co-immunoprecipitation and complex formation assays to study RUBCNL-RIPK1 interactions.
  • Assessment of RUBCNL's impact on TNF signaling complex assembly.

Main Results:

  • RUBCNL expression protected MSCs from TNF-induced regulated cell death (RCD).
  • RUBCNL negatively regulated both RIPK1-dependent apoptosis and necroptosis.
  • RUBCNL's cell death regulatory function was independent of its autophagy regulatory role.
  • RUBCNL formed a complex with RIPK1, which disassembled upon TNF stimulation.
  • RUBCNL limited the assembly of the RIPK1-TNFRSF1A/TNFR1 complex, repressing TNF signaling.

Conclusions:

  • RUBCNL acts as a negative regulator of TNF-induced apoptosis and necroptosis in MSCs.
  • RUBCNL's dual role in autophagy and cell death pathways offers a novel therapeutic target.
  • Targeting RUBCNL could improve MSC survival and therapeutic efficacy in inflammatory conditions.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K